Call Now to Speak with a Care Manager Speak with a Care Manager Now: 778-279-3634

New Brain Imaging Drug Helps Detect Alzheimer’s

By Carolina Orosa, 4:59 pm on

As senior citizens age, they may begin to experience symptoms of cognitive decline similar to those commonly found in people with Alzheimer’s and dementia. These conditions can be hard to diagnose. However, over the past few years, new diagnostic tests have been developed, including the new brain imaging drug called Vizamyl.

At Home Care Assistance of Vancouver, we’re always keeping an eye out for new information and studies on memory care and wanted to share what we’ve learned about this new brain imaging drug. With advancements being made each day, we’re joining the many individuals throughout North America who believe that an Alzheimer’s treatment is in our future.

What is Vizamyl?

Vizamyl (Flutemetamol F 18 injection) is a new brain-imaging drug manufactured by Medi-Physics, Inc. in Arlington Heights, Illinois. It is manufactured for a company called GE Healthcare and was approved by the United Stated States Food and Drug Administration (FDA) in 2013.

How Does Vizamyl Work?

Vizamyl is a radioactive drug that is injected into the body and is detected in the brain using Positron Emission Tomography (PET) imaging. It works because Vizamyl attaches to beta amyloid, which are protein fibers that can accumulate in the brain. The proteins are naturally found in the body but, in the case of people with Alzheimer’s and other dementia, become folded and build up producing plaques in the brain. However, plaques are sometimes found in the brains of people who do not have Alzheimer’s or dementia.

What Do the PET Scan Results Mean?

A scan is produced as part of the PET imaging procedure and a medical professional interprets it with a rating of either negative or positive. A negative scan means that little to no plaques were found in the brain and that the patient most likely does not have Alzheimer’s. A positive scan means a moderate to frequent amount of plaques were found and that the patient may have Alzheimer’s or other types of dementia. Other tests are used along with Vizamyl to fully diagnose Alzheimer’s and other types of dementia.

The Future of Vizamyl

Vizamyl is considered safe with only a very small percentage of people having adverse reactions to the drug. This drug not only shows promise in helping doctors to diagnose Alzheimer’s but it may also help scientists find a cure through the elimination of beta amyloid.

If you have an aging parent, grandparent or loved one who has been diagnosed with Alzheimer’s, learn more about in-home Alzheimer’s care in Vancouver, provided by Home Care Assistance. We are a trusted provider of the medical community and offer flexible hourly and live-in schedules, allowing our clients to choose the type of care they need, when they need it. For more information or to schedule a free, in-home consultation, call 778-279-3634 to speak with a Case Manager.